{
  "@context": ["file://domain/_contexts/base.jsonld", "file://domain/_contexts/medicine.jsonld"],
  "@type": ["EducationalResource", "MedicalEntity"],
  "@id": "hht-001-definition",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-05T02:52:00.000Z",
    "contributors": ["copilot-agent", "vascular-surgery-knowledge-base"],
    "confidence": 0.96,
    "status": "validated",
    "last_updated": "2026-01-05T02:52:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/genetic-connective-tissue",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "medium",
    "aku_id": "005",
    "keywords": ["hereditary hemorrhagic telangiectasia", "HHT", "Osler-Weber-Rendu", "epistaxis", "pulmonary AVM"],
    "medical_specialty": "vascular_surgery"
  },
  "content": {
    "statement": {
      "text": "Hereditary hemorrhagic telangiectasia (HHT), or Osler-Weber-Rendu disease, is an autosomal dominant vascular disorder characterized by mucocutaneous telangiectasias and visceral arteriovenous malformations (AVMs). Mutations in ENG (HHT1) or ACVRL1/ALK1 (HHT2) impair TGF-β signaling in vascular development. Clinical manifestations include epistaxis, GI bleeding, pulmonary AVMs, and cerebral/hepatic AVMs.",
      "formal": "HHT: AD vascular disorder; Genes: ENG (HHT1), ACVRL1 (HHT2); Manifestations: telangiectasias (nose, lips, fingers, GI), visceral AVMs (pulmonary 30-50%, hepatic 30-70%, cerebral 10%)"
    },
    "explanation": {
      "intuition": "HHT is like having fragile, malformed blood vessels throughout the body. Normal capillaries are replaced by direct connections between arteries and veins (telangiectasias and AVMs). These abnormal vessels are fragile and prone to bleeding. Some are visible on the skin and lips, but the dangerous ones are hidden in the lungs and brain, where they can cause stroke, brain abscess, or catastrophic bleeding.",
      "key_insight": "Pulmonary AVMs in HHT bypass the lung's natural filter function, allowing clots and bacteria to travel directly to the brain. This causes paradoxical embolic stroke and brain abscess in seemingly 'healthy' young patients. All HHT patients need screening for pulmonary AVMs and prophylactic treatment if feeding arteries are ≥3mm.",
      "technical_details": "Curacao diagnostic criteria: (1) spontaneous recurrent epistaxis, (2) mucocutaneous telangiectasias, (3) visceral AVMs, (4) first-degree relative with HHT. Definite diagnosis: 3+ criteria. HHT1 (ENG) has higher pulmonary and cerebral AVM prevalence. HHT2 (ACVRL1) has higher hepatic involvement. SMAD4 mutations cause HHT-juvenile polyposis overlap."
    },
    "curacao_criteria": {
      "criteria": [
        "Epistaxis - spontaneous, recurrent nosebleeds",
        "Telangiectasias - multiple, characteristic locations (lips, oral cavity, fingers, nose)",
        "Visceral AVMs - pulmonary, hepatic, cerebral, spinal, GI",
        "Family history - first-degree relative with HHT"
      ],
      "interpretation": {
        "definite": "≥3 criteria",
        "possible": "2 criteria",
        "unlikely": "0-1 criteria"
      }
    }
  },
  "clinical_features": {
    "manifestations": {
      "epistaxis": {"prevalence": "90-95%", "onset": "Usually by age 20", "severity": "Variable - can be severe, require transfusion"},
      "telangiectasias": {"prevalence": "70-80%", "locations": ["Lips", "Tongue", "Fingers", "Nasal mucosa"], "onset": "Increase with age"},
      "pulmonary_avm": {"prevalence": "30-50%", "complications": ["Paradoxical embolism (stroke)", "Brain abscess", "Hypoxemia", "Hemoptysis"], "screening": "Contrast echocardiography, then CT if positive"},
      "hepatic_avm": {"prevalence": "30-70%", "complications": ["High-output heart failure", "Portal hypertension", "Biliary ischemia"]},
      "cerebral_avm": {"prevalence": "10-20%", "complications": ["Hemorrhagic stroke"]},
      "gi_telangiectasias": {"prevalence": "25-30%", "complications": ["Chronic GI bleeding", "Iron deficiency anemia"]}
    },
    "treatment": {
      "epistaxis": ["Humidification", "Nasal lubricants", "Laser ablation", "Septodermoplasty", "Bevacizumab (anti-VEGF)"],
      "pulmonary_avm": {"screening": "All patients at diagnosis and q5-10 years", "treatment": "Transcatheter embolization if feeding artery ≥3mm"},
      "gi_bleeding": ["Iron supplementation", "Transfusion", "Argon plasma coagulation", "Bevacizumab"],
      "hepatic_avm": ["Medical heart failure management", "Liver transplant for severe cases", "Avoid embolization (biliary necrosis risk)"]
    }
  },
  "skos": {
    "prefLabel": {"@language": "en", "@value": "Hereditary Hemorrhagic Telangiectasia"},
    "altLabel": [{"@language": "en", "@value": "HHT"}, {"@language": "en", "@value": "Osler-Weber-Rendu Disease"}],
    "definition": {"@language": "en", "@value": "Autosomal dominant vascular disorder with mucocutaneous telangiectasias and visceral AVMs causing bleeding and paradoxical emboli"},
    "notation": "hht-001-definition"
  },
  "relationships": {
    "skos:broader": [{"@id": "urn:wskg:medicine:surgery:vascular:pathology:genetic-connective-tissue", "@type": "skos:Concept", "skos:prefLabel": "Genetic Vascular Disorders"}],
    "skos:related": [{"@id": "urn:wskg:medicine:surgery:vascular:pathology:vascular-malformations:avm", "@type": "skos:Concept", "skos:prefLabel": "AVM"}]
  },
  "pedagogical": {
    "estimated_time": "20min",
    "clinical_pearls": [
      "Young stroke or brain abscess = screen for HHT and pulmonary AVM",
      "All HHT patients need pulmonary AVM screening (contrast echo → CT if positive)",
      "Antibiotic prophylaxis before dental procedures if pulmonary AVMs present",
      "Do NOT embolize hepatic AVMs - causes biliary necrosis"
    ]
  },
  "medicalCode": [
    {"@type": "MedicalCode", "codingSystem": "SNOMED-CT", "codeValue": "21877004", "description": "Hereditary hemorrhagic telangiectasia"},
    {"@type": "MedicalCode", "codingSystem": "ICD-10-CM", "codeValue": "I78.0", "description": "Hereditary hemorrhagic telangiectasia"},
    {"@type": "MedicalCode", "codingSystem": "OMIM", "codeValue": "187300", "description": "Telangiectasia, hereditary hemorrhagic, type 1"}
  ]
}
